These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11296186)

  • 1. Long-term intermittent dobutamine infusion combined with oral amiodarone improves the survival of patients with severe congestive heart failure.
    Nanas JN; Kontoyannis DA; Alexopoulos GP; Anastasiou-Nana MI; Tsagalou EP; Stamatelopoulos SF; Moulopoulos SD
    Chest; 2001 Apr; 119(4):1173-8. PubMed ID: 11296186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study.
    Nanas JN; Tsagalou EP; Kanakakis J; Nanas SN; Terrovitis JV; Moon T; Anastasiou-Nana MI
    Chest; 2004 Apr; 125(4):1198-204. PubMed ID: 15078725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
    Nanas JN; Tsagalou EP; Nanas SN; Terrovitis JV; Tsolakis EJ; Toumanidis S; Papazoglou PD; Alexopoulos GP; Kanakakis J; Anastasiou-Nana MI
    Int J Cardiol; 2006 Apr; 108(2):237-43. PubMed ID: 16183152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone attenuates the proarrhythmic effects of dobutamine in patients with advanced congestive heart failure.
    Tsagalou EP; Gounopoulos P; Terrovitis JV; Drakos SG; Katsaros FT; Kaldara EE; Alexopoulos GP; Anastasiou-Nana MI
    Hellenic J Cardiol; 2009; 50(3):193-8. PubMed ID: 19465360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.
    Oliva F; Latini R; Politi A; Staszewsky L; Maggioni AP; Nicolis E; Mauri F
    Am Heart J; 1999 Aug; 138(2 Pt 1):247-53. PubMed ID: 10426835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term survival benefit conferred by intermittent dobutamine infusions and oral amiodarone is greater in patients with idiopathic dilated cardiomyopathy than with ischemic heart disease.
    Tsagalou EP; Anastasiou-Nana MI; Terrovitis JV; Nanas SN; Alexopoulos GP; Kanakakis J; Nanas JN
    Int J Cardiol; 2006 Apr; 108(2):244-50. PubMed ID: 16023232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.
    Rich MW; Woods WL; Davila-Roman VG; Morello PJ; Kurz H; Barbarash R; Spinner L; Sperry J; Beckham V; Coulter L
    J Am Geriatr Soc; 1995 Mar; 43(3):271-4. PubMed ID: 7884117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S; Di Pasquale P; Parrinello G; Amato P; Cardinale A; Follone G; Giubilato A; Licata G
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone.
    Nanas JN; Papazoglou PP; Terrovitis JV; Kanakakis J; Dalianis A; Tsolakis E; Tsagalou EP; Agrios N; Christodoulou K; Anastasiou-Nana MI
    Am J Cardiol; 2004 Nov; 94(10):1329-32. PubMed ID: 15541261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study.
    Elis A; Bental T; Kimchi O; Ravid M; Lishner M
    Clin Pharmacol Ther; 1998 Jun; 63(6):682-5. PubMed ID: 9663183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of short-term intermittent intravenous dobutamine therapy on endothelial function in patients with severe chronic heart failure.
    Freimark D; Feinberg MS; Matezky S; Hochberg N; Shechter M
    Am Heart J; 2004 Nov; 148(5):878-82. PubMed ID: 15523321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone.
    Nanas JN; Papazoglou P; Tsagalou EP; Ntalianis A; Tsolakis E; Terrovitis JV; Kanakakis J; Nanas SN; Alexopoulos GP; Anastasiou-Nana MI
    Am J Cardiol; 2005 Mar; 95(6):768-71. PubMed ID: 15757608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients.
    Frey B; Pacher R; Locker G; Bojic A; Hartter E; Woloszczuk W; Stanek B
    Chest; 2000 Jun; 117(6):1713-9. PubMed ID: 10858407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dobutamine in severe scorpion envenomation: effects on standard hemodynamics, right ventricular performance, and tissue oxygenation.
    Elatrous S; Nouira S; Besbes-Ouanes L; Boussarsar M; Boukef R; Marghli S; Abroug F
    Chest; 1999 Sep; 116(3):748-53. PubMed ID: 10492282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient parenteral inotropic therapy for advanced heart failure.
    Young JB; Moen EK
    J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S49-57. PubMed ID: 11016488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study.
    Pacher R; Globits S; Wutte M; Rödler S; Heinz G; Kreiner G; Radosztics S; Berger R; Presch I; Weber H
    Crit Care Med; 1994 Jul; 22(7):1084-90. PubMed ID: 8026195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine.
    Stanek B; Sturm B; Frey B; Hülsmann M; Bojic A; Berger R; Rödler S; Locker G; Grimm M; Laufer G; Pacher R
    J Heart Lung Transplant; 1999 Apr; 18(4):358-66. PubMed ID: 10226901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.
    Karlsberg RP; DeWood MA; DeMaria AN; Berk MR; Lasher KP
    Clin Cardiol; 1996 Jan; 19(1):21-30. PubMed ID: 8903534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.